Pulmonary Arterial Hypertension (PAH) is a disease referring to high blood pressure in the pulmonary arteries. PAH is characterized by vascular remodeling, and often results in heart failure with a 48% 3 year survival rate (Gerringer). The current method of treating PAH uses invasive procedures and medications with severe side effects (Humbert). The only cure is a lung transplant (Pursell). Furthermore, PAH is a widespread disease as estimates show that 15-25 million people were afflicted with PAH in 2020 (Dubroff).